Literature DB >> 16302267

A preliminary analysis and model of prostate injection distributions.

Scott L Chowning1, Robert C Susil, Axel Krieger, Gabor Fichtinger, Louis L Whitcomb, Ergin Atalar.   

Abstract

PURPOSE: Understanding the internal dynamics of prostate injections, particularly injection pattern distribution is a key step to developing new therapies for prostate disease that may be best served with a direct injection approach. Due to excellent properties involving liquid contrast agents, MRI can be used for targeting and monitoring of injections into organs and tissues.
MATERIALS AND METHODS: Eleven intraprostatic injections were performed in vivo with canines using a custom transrectal guiding and imaging system for use in a standard 1.5 T MR scanner. In addition, 25 injections were performed on excised cadaveric human prostates, using a MedRad Spectris injector system. MRI was used to guide the injections and monitor intraparenchymal injection distribution.
RESULTS: T1 and T2-weighted MR images were correlated with histology to produce three-dimensional data sets that can be used to analyze trends in injection patterns. This analysis was used to develop strategies for injection prediction such as gadolinium pre-injections and diffusion-weighted imaging guidance. In addition, a rough model of prostate injections is described, and a preliminary injection guide is developed that takes into account the individual clinician's goals for therapy.
CONCLUSIONS: MR visualization of injected therapeutic agents allows for prediction and monitoring of drug distributions, possibly improving efficacy and reducing side effects. Injection analysis and modeling may be used to assist in optimizing clinical treatments that require or would benefit from focal parenchymal injections into the prostate. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16302267     DOI: 10.1002/pros.20298

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

1.  An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention.

Authors:  Axel Krieger; Iulian I Iordachita; Peter Guion; Anurag K Singh; Aradhana Kaushal; Cynthia Ménard; Peter A Pinto; Kevin Camphausen; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE Trans Biomed Eng       Date:  2011-11       Impact factor: 4.538

2.  Robotic system for MRI-guided prostate biopsy: feasibility of teleoperated needle insertion and ex vivo phantom study.

Authors:  Reza Seifabadi; Sang-Eun Song; Axel Krieger; Nathan Bongjoon Cho; Junichi Tokuda; Gabor Fichtinger; Iulian Iordachita
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-06-23       Impact factor: 2.924

3.  Biopsy needle artifact localization in MRI-guided robotic transrectal prostate intervention.

Authors:  Sang-Eun Song; Nathan Bongjoon Cho; Iulian I Iordachita; Peter Guion; Gabor Fichtinger; Aradhana Kaushal; Kevin Camphausen; Louis L Whitcomb
Journal:  IEEE Trans Biomed Eng       Date:  2012-04-03       Impact factor: 4.538

4.  Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.

Authors:  Axel Krieger; Sang-Eun Song; Nathan B Cho; Iulian Iordachita; Peter Guion; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE ASME Trans Mechatron       Date:  2011-10-17       Impact factor: 5.303

Review 5.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

6.  Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer.

Authors:  Sandra M Axiak-Bechtel; Anandhi Upendran; Jimmy C Lattimer; James Kelsey; Cathy S Cutler; Kim A Selting; Jeffrey N Bryan; Carolyn J Henry; Evan Boote; Deborah J Tate; Margaret E Bryan; Kattesh V Katti; Raghuraman Kannan
Journal:  Int J Nanomedicine       Date:  2014-10-28

7.  A pilot study in intraparenchymal therapy delivery in the prostate: a comparison of delivery with a porous needle vs standard needle.

Authors:  Martin L Brady; King Scott Coffield; Thomas J Kuehl; Raghu Raghavan; V O Speights; Belur Patel; Scott Wilson; Mike Wilson; Rick M Odland
Journal:  BMC Urol       Date:  2018-07-28       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.